Axogen Inc vs Kyndryl Holdings Inc — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Kyndryl Holdings Inc trades at $11.68 (market cap $2.56B). The key difference: Kyndryl Holdings Inc is the larger of the two by market cap, and Axogen Inc is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | KD | |
|---|---|---|
Market Cap | $2.06B | $2.56B |
Sector | Technology | Technology |
52-Week High | $46.19 | $39.47 |
52-Week Low | $11.28 | $10.59 |
Enterprise Value | $1.98B | $4.89B |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Kyndryl Holdings (KD) trades at $12.32, up 2.92% with a bullish technical signal. The company shows improving fundamentals with 2025 net income turning positive at $252M after years of losses, though recent quarterly earnings missed expectations. Valuation remains attractive with P/E of 14.49 and EV/EBITDA of 3.19. Recent partnerships with Microsoft and AWS for AI solutions highlight strategic positioning.
Outlook remains cautiously optimistic with analyst consensus target of $14.33 offering 16% upside. Key risks include ongoing earnings volatility, internal control investigations, and high debt levels. The transformation toward higher-margin services provides growth potential, but execution risks and competitive pressures require monitoring.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →